Yena Lee

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

Impact of cognitive-affective and somatic symptoms in subthreshold depression transition in adults: Evidence from Depression Cohort in China (DCC)

Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death

Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review

Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis

Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders

Deficits of social cognition in bipolar disorder: Systematic review and meta‐analysis

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression

Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder

Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine

Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review

Determinants of Cognitive Function in Individuals with Type 2 Diabetes Mellitus: A Meta-Analysis

Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression

Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers

The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction

Guidelines for the recognition and management of mixed depression

Cannabidiol in medical marijuana: Research vistas and potential opportunities

Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review

Drug-drug interactions as a result of co-administering Δ⁹-THC and CBD with other psychotropic agents

Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders